Search
What All Lawyers Need To Know About The State Of Immigration Law This white paper explores some of the biggest challenges you can expect to face when practicing immigration law. By ABOVE THE LAW AND EMBROKER
Controversial US Visa Draws Rich From China to India After Reset The EB-5 visa program coveted by many wealthy overseas investors is being revived after changes aimed at curbing abuses. By Blake Schmidt
CRE Investment Hot Streak Doused By Down Economy Economic forces at play across the globe, including the rising cost of capital and the threat of a U.S. recession have caused investors to think twice about how and where to place their money, with several leading indicators of deal volume slipping...
FUND ADMINISTRATION VS. ANNUAL AUDIT Rohit Kapuria, a Partner in the Firm's EB-5 Practice, will speak during a JTC Americas webinar. On 6/24/22, a federal court granted a preliminary injunction in the case of Behring Regional Center, LLC, v. Alejandro Mayorkas, et al., overturning the USCIS’s...
NEXT STEPS FOR INVESTORS AND DETAILS ON SALTAIRE (URBAN) & TWIN LAKES (RURAL) PROJECTS Rohit Kapuria, a Partner in the Firm's EB-5 Practice, to speak at an EB5 Affiliate Network Webinar. The webinar will cove the current state of the EB-5 Regional Center Program following the recent court ruling...
Saul Ewing LLP represented Genesis Unicorn Capital, LLC, in its acquisition of and role as the sole sponsor for Genesis Unicorn Capital Corp. a special purpose acquisition company (SPAC), in the SPAC's $75 Million initial public offering (IPO) of 7,500,000 units at a price of $10.00 per unit. The...
Saul Ewing LLP represented Signal Hill Acquisition Corp., a special purpose acquisition company, in its initial public offering of 10,000,000 units at a price of $10.00 per unit, resulting in gross proceeds of $100,000,000. The units are listed on The Nasdaq Global Market (Nasdaq) and began trading...
Veronica McCarty is a litigator who represents inventors and companies in intellectual property disputes, particularly for inventions involving computing and biopharmaceutical technologies, as well as medical devices. Veronica works on patent trials, including on ANDA bench trials, and she assists...
Industry-Specific, Business-Focused Legal Advice Increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty have squeezed the margins of life sciences companies. Helping navigate this ever-shifting terrain, Saul Ewing’s Life Sciences Practice consists...
Eric Orlinsky co-chairs the firm's Corporate Practice and its Private Equity/Venture Capital subgroup and concentrates his practice in general business and securities law and counsels clients in private equity and venture capital investments, public and private offerings of debt and equity...
Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...
Joe Lipchitz represents businesses, officers, directors, and high-level executives in the technology, health care, financial services, and media industries in civil litigation nationwide, particularly in high-stakes disputes. Drawing on his more than 20 years of experience as a trial lawyer, Joe...
Michael Petrizzo brings nearly 30 years of experience to his work guiding clients through mergers and acquisitions, financing transactions, and corporate formations, reorganizations and restructurings. Public and private companies, private equity and venture capital firms, and high-net-worth...